Fundraising Fox

Sarsia Management AS

Venture capital

Bergen · Seed–Series A · 13 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Sarsia is an early-stage venture capital firm investing across two main areas: life sciences, targeting unmet medical needs where capital and expertise can turn laboratory research into effective patient treatments; and technology, energy and sustainability, backing founders and technologies that can accelerate the green transition and build sustainable companies. The firm emphasizes technologies that improve quality of life and society while reducing negative environmental impact, connecting strong science and solutions with competent capital. Drawing on a team with diverse backgrounds and perspectives, Sarsia takes on risk to create value and is one of the top-performing early-stage venture funds in the Nordic region.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
Check
$190K – $475K
HQ
Bergen, NO
Leads rounds
Leads
Instruments
Equity
Founded
2006
AUM
$130M
Tracked investments
48

Team · 13 people

from the firm's website & public directories

What they invest in

from 1 of 48 portfolio companies

Biotech ×1Cleantech ×1Climate Tech ×1

HQs:Norway×1

Investments · 48 tracked

founders shown can be your intro path
Apim Therapeutics As
Aquiloz
Bergenbio Asa
Blue Limit
C10 Pharma
Caedo Oncology
Calluna Pharma

Completed patient enrollment in its Phase 2 AURORA trial.

Cetasol
Chargitect
Coegin Pharma
Delante Health
Elekt
Enso
Enua
Flow Computing
Geneseque
Green Power Hub
Heimdall Powerheimdallpower.comin

Digitalizes the power grid to enable better use of existing infrastructure

Hepmarin
Insentio
Keelspot
Medstorm Innovation As
Mitigrate
Movel
Nisonic As
Oculaudio
Offshore Sensing
Pacertool
Pluvia

Received investment from the US PKU patient advocacy organization NPKUA.

Pluvia Biotech

Biotech company working in the PKU (phenylketonuria) space.

Prophylix Pharma As
Qbee
Scandinavian Biopharma
Screencancer As
Sea Hawk Navigation As
Seafarm Solutions As
Seasmart
Serca Pharmaceuticals
Soiltech
SonoClear AS

Completed the final patient procedure in a study of its SonoWand-related product.

Sorbwater As
Trisense As
Vaccibody As
Vestland Pharma AS

Sarsia is an early-stage venture capital firm that invests in life sciences companies addressing unmet medical needs and technology companies advancing the green transition and sustainability.

BiotechCleantechClimate Tech

Volusense
Weyland
Windsim As
Xsensxsens.no

High accuracy clamp-on flow rate and phase fraction meter for gas, oil, water and drilling mud systems.

Frequently asked questions

What stage does Sarsia Management AS invest at?
Sarsia Management AS invests at the Seed, Series A stages.
What is Sarsia Management AS's typical check size?
Sarsia Management AS typically writes checks of $190K – $475K.
What sectors does Sarsia Management AS focus on?
Sarsia Management AS focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, Semiconductors.
Where is Sarsia Management AS located?
Sarsia Management AS is headquartered in Bergen, NO.
Does Sarsia Management AS lead rounds?
Yes, Sarsia Management AS leads investment rounds.

Similar investors

Featured in lists